Table 2.
Clinical characteristics of new patients with pulmonary tuberculosis in Medellín, Colombia, May–September 2017
| Clinical characteristics | Total | PD | HSD | |||
|---|---|---|---|---|---|---|
| n (%) | Me [IQR] | Me [IQR] | ||||
| 183 (100) | 35 [14–84] | 27 [7–89] | ||||
| Tobacco | ||||||
| No tobacco use | 111 | (60.66) | 30 | [14–91] | 41 | [11–106] |
| Past tobacco use | 37 | (20.21) | 48 | [9–75] | 17 | [6–62] |
| Current tobacco use | 35 | (19.13) | 61 | [28–87] | 13 | [4–51] |
| Alcohol consumption | ||||||
| No | 150 | (81.97) | 31 | [14–74] | 31 | [8–92] |
| Former consumer | 15 | (8.20) | 63 | [19–101] | 15 | [6–50] |
| Currently | 18 | (9.83) | 56 | [15–106] | 13 | [7–67] |
| PAS consumption | ||||||
| No | 153 | (83.61) | 30 | [14–65] | 33 | [9–93] |
| Former consumer | 8 | (4.37) | 70 | [20–178] | 20.5 | [6–35] |
| Currently | 22 | (12.02) | 68.5 | [40–127] | 12.5 | [3–30] |
| Medical history diabetes | ||||||
| No | 158 | (86.34) | 34 | [14–84] | 28 | [9–92] |
| Yes | 25 | (13.66) | 61 | [25–91] | 13 | [4–64] |
| Haemoptysis | ||||||
| No | 147 | (80.33) | 35 | [14–90] | 26 | [7–73] |
| Yes | 36 | (19.67) | 34 | [15–64] | 34 | [9–118] |
| HIV serological status | ||||||
| Negative | 166 | (90.71) | 35 | [15–84] | 26.5 | [7–78] |
| Positive | 17 | (9.29) | 35 | [14–61] | 33 | [11–100] |
| AFB smear | ||||||
| Positive | 139 | (75.96) | – | 17 | [7–63] | |
| Negative | 44 | (24.04) | – | 69 | [27–130] | |
| Close contact with TB patient | ||||||
| No | 139 | (75.96) | 31 | [14–64] | 32 | [9–105] |
| Yes | 44 | (24.04) | 63 | [29–124] | 15 | [7–65] |
| Chest X-ray | ||||||
| Yes | 169 | (92.35) | – | 29 | [7–89] | |
| No | 14 | (7.65) | – | 13.5 | [13–29] | |
PD patient delay; HSD health system delay; Me median; IQR interquartile range; PAS psychoactive substances; HIV human immunodeficiency virus; AFB acid-fast bacilli
Note: The variables AFB smear and chest x-rays were not kept in mind for the PD